Topics
Glioblastoma | Treatment | Clinical trials | Antiemetic drugs
Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Antiemetic drugs
Affronti ML, Patel MP, Severance
EK, Loughlin C, Bradbury C, Herndon JE, Boyd K, Lipp ES, Friedman
HS, Desjardins A, Johnson MO, Peters KB.
Phase
II randomized glioma study to evaluate efficacy and satisfaction
of rolapitant plus ondansetron in preventing
chemoradiation-induced nausea and vomiting.
Neurooncol
Pract. 2025 Jan
28;12(4):618-630. doi:
10.1093/nop/npaf014. PMID:
40814434. Interventional
study˰ Meeting
abstract.
ˍ
AI
Overview